<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00753363</url>
  </required_header>
  <id_info>
    <org_study_id>AGCG-003-05F</org_study_id>
    <nct_id>NCT00753363</nct_id>
  </id_info>
  <brief_title>Exercise and Inflammation in the Elderly</brief_title>
  <acronym>IRIS</acronym>
  <official_title>Exercise, Inflammation and Pro-thrombotic Modulators in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Persistent low-grade inflammation and impaired fibrinolysis, are independent predictors of
      several chronic diseases highly prevalent in the older Veteran population including
      cardiovascular disease (CVD), stroke, and diabetes. Inflammation is likely to be a causative
      underlying mechanism of insulin resistance. Lifestyle changes such as weight loss and
      physical activity are advocated for the treatment of these chronic diseases and endpoints,
      and data are emerging which suggest that these treatments may be beneficial, in part, due to
      their anti-inflammatory effects. Identification of effective therapies that reduce chronic
      inflammation for Veterans is important given the widespread adverse health effects of a
      chronically elevated inflammatory state.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will compare the effects of 6 month trial of aerobic exercise (AEX) vs. weight
      loss (WL) in older individuals on:

        1. adipokine secretion and expression (tumor necrosis factor alpha, adiponectin);

        2. adipose tissue and skeletal muscle inflammatory proximal receptor expression
           (adiponectin and tumor necrosis factor alpha expression) and signaling pathways; and

        3. whether the changes in signal transduction are associated with changes in peripheral
           whole body insulin sensitivity by a hyperinsulinemic-euglycemic clamp.

      The prevention and treatment of insulin resistance, the metabolic syndrome, and their CVD
      complications through exercise and weight loss could improve Veterans' health and reduce
      health care costs. Knowledge of their effectiveness has important implications for the
      cardiovascular health of Veterans given the widespread adverse health effects of chronic
      inflammation on vascular biology, skeletal muscle function and insulin action.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2007</start_date>
  <completion_date type="Anticipated">November 29, 2018</completion_date>
  <primary_completion_date type="Actual">November 29, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>Baseline and 6 month</time_frame>
    <description>Insulin resistance is defined as a reduction in glucose utilization rate elicited by a given insulin concentration. Glucose utilization is measured during a three hour hyperinsulinemic-euglycemic clamp and is presented as a measure of insulin sensitivity. This is one of the most sophisticated methods to measure insulin sensitivity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Weight</measure>
    <time_frame>Baseline and 6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fitness</measure>
    <time_frame>Baseline and 6 month</time_frame>
    <description>Maximal oxygen consumption (VO2max) on a treadmill</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">119</enrollment>
  <condition>Inflammation</condition>
  <condition>Insulin Sensitivity</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 months of aerobic exercise training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 months of weight loss</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Weight Loss</intervention_name>
    <description>6 months of weight loss</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic Exercise Training</intervention_name>
    <description>6 months of aerobic exercise training</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and Female

          -  45-80 yrs of age

          -  Non-smoking for one year

          -  Body mass index greater than 20 kg/m2 and less than 50 kg/m2

          -  Menopause over 1 year

        Exclusion Criteria:

          -  Symptomatic heart disease, coronary artery disease, congestive heart failure, or
             uncontrolled hypertension (blood pressure over 180/100 mm Hg) unless medically
             stabilized

          -  Currently being treated for active cancer

          -  Type 1 diabetes; Insulin or oral agent treatment for diabetes, poorly controlled
             diabetes fasting blood glucose over 160 mg/dl

          -  Allergic to lidocaine

          -  Untreated dyslipidemia with National Cholesterol Adult Treatment Panel III 10 year
             cardiac risk score greater than 10%, or receiving triglyceride lowering meds

          -  Other systemic disorders that are not medically treated and stable

          -  Taking beta-blockers, oral steroids, warfarin or any other medications interfering
             with fat/muscle metabolism that may not be safely discontinued temporarily for
             specific procedures (ie for 72 hours prior)

          -  Abnormal response to exercise test (ST segment depression greater than 2mm, chest
             pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising BP
             above 240/120mm Hg, or other contraindications to exercise) *requires follow up
             treatment w/ primary MD for continued participation in study

          -  Abnormal liver function

          -  Abnormal renal function

          -  Chronic pulmonary disease

          -  Anemia hematocrit below 35 mg/dl, platelets below 100,000/cm3

          -  Mini-mental state exam below 24, dementia or unstable clinical depression by exam

          -  Aerobically trained with maximal oxygen consumption greater than 2 standard deviations
             above age-adjusted mean

          -  Exercise group only: History of cerebrovascular disease (by medical history) with
             symptoms limiting the ability to exercise
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alice S Ryan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2008</study_first_submitted>
  <study_first_submitted_qc>September 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2008</study_first_posted>
  <results_first_submitted>October 15, 2014</results_first_submitted>
  <results_first_submitted_qc>December 16, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 22, 2014</results_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glucose Metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1</title>
          <description>6 months of aerobic exercise training
Aerobic Exercise Training: 6 months of aerobic exercise training</description>
        </group>
        <group group_id="P2">
          <title>Arm 2</title>
          <description>6 months of weight loss
Weight Loss: 6 months of weight loss</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>6 months of aerobic exercise training
Aerobic Exercise Training: 6 months of aerobic exercise training</description>
        </group>
        <group group_id="B2">
          <title>Arm 2</title>
          <description>6 months of weight loss
Weight Loss: 6 months of weight loss</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="59"/>
            <count group_id="B2" value="60"/>
            <count group_id="B3" value="119"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" lower_limit="45" upper_limit="81"/>
                    <measurement group_id="B2" value="61" lower_limit="49" upper_limit="74"/>
                    <measurement group_id="B3" value="61" lower_limit="45" upper_limit="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.4" spread="6.0"/>
                    <measurement group_id="B2" value="35.7" spread="4.4"/>
                    <measurement group_id="B3" value="34.1" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Insulin Sensitivity</title>
        <description>Insulin resistance is defined as a reduction in glucose utilization rate elicited by a given insulin concentration. Glucose utilization is measured during a three hour hyperinsulinemic-euglycemic clamp and is presented as a measure of insulin sensitivity. This is one of the most sophisticated methods to measure insulin sensitivity.</description>
        <time_frame>Baseline and 6 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>6 months of aerobic exercise training
Aerobic Exercise Training: 6 months of aerobic exercise training</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>6 months of weight loss
Weight Loss: 6 months of weight loss</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Sensitivity</title>
          <description>Insulin resistance is defined as a reduction in glucose utilization rate elicited by a given insulin concentration. Glucose utilization is measured during a three hour hyperinsulinemic-euglycemic clamp and is presented as a measure of insulin sensitivity. This is one of the most sophisticated methods to measure insulin sensitivity.</description>
          <units>Î¼mol/kgFFM/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.2" spread="4.5"/>
                    <measurement group_id="O2" value="40.7" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.5" spread="4.9"/>
                    <measurement group_id="O2" value="42.3" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Weight</title>
        <time_frame>Baseline and 6 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>6 months of aerobic exercise training
Aerobic Exercise Training: 6 months of aerobic exercise training</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>6 months of weight loss
Weight Loss: 6 months of weight loss</description>
          </group>
        </group_list>
        <measure>
          <title>Body Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.3" spread="3.8"/>
                    <measurement group_id="O2" value="103.0" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.1" spread="4.2"/>
                    <measurement group_id="O2" value="93.7" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fitness</title>
        <description>Maximal oxygen consumption (VO2max) on a treadmill</description>
        <time_frame>Baseline and 6 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>6 months of aerobic exercise training
Aerobic Exercise Training: 6 months of aerobic exercise training</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>6 months of weight loss
Weight Loss: 6 months of weight loss</description>
          </group>
        </group_list>
        <measure>
          <title>Fitness</title>
          <description>Maximal oxygen consumption (VO2max) on a treadmill</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.38" spread="0.14"/>
                    <measurement group_id="O2" value="2.34" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.70" spread="0.15"/>
                    <measurement group_id="O2" value="2.29" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected between baseline and 6 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>6 months of aerobic exercise training
Aerobic Exercise Training: 6 months of aerobic exercise training</description>
        </group>
        <group group_id="E2">
          <title>Arm 2</title>
          <description>6 months of weight loss
Weight Loss: 6 months of weight loss</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dizzy and nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alice Ryan</name_or_title>
      <organization>Baltimore VAMC</organization>
      <phone>410-605-7851</phone>
      <email>aryan@grecc.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

